Back to Trades
Pauls Matthew
DirectorCIK 0001573429
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 4
- Active
- 2025–2026
Across 9 filings between 2025–2026, Pauls Matthew, Director, has disclosed $2.4M in transactions — spread across 4 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $37.0K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Jul 7 | PTHS Pelthos Therapeutics Inc. | Pauls Matthew | Director | Sell | $20.6K |
| Jul 1 | PVLA PALVELLA THERAPEUTICS, INC. | Pauls Matthew | Director | Award | $929.0K |
| Jul 1 | PVLA PALVELLA THERAPEUTICS, INC. | Pauls Matthew | Director | Other | $0 |
| May 18 | SLNO SOLENO THERAPEUTICS INC | Pauls Matthew | Insider | Disposed | $41.7K |
| Apr 6 | PTHS Pelthos Therapeutics Inc. | Pauls Matthew | Director | Sell | $16.4K |
| Apr 1 | PTHS Pelthos Therapeutics Inc. | Pauls Matthew | Director | Grant | $0 |
| Dec 16 | SVRA Savara Inc | Pauls Matthew | Insider | Gift | $1.4M |
| Dec 12 | PTHS Pelthos Therapeutics Inc. | Pauls Matthew | Director | Gift | $0 |
| Dec 11 | SVRA Savara Inc | Pauls Matthew | Insider | Gift | $0 |
9 filings